Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Semaglutide | Participants in this group will receive semaglutide once weekly injection in addition to their standard closed-loop therapy Semaglutide: Semaglutide up to 1 mg per week in addition to standard closed-loop therapy | 0 | None | 1 | 36 | 26 | 36 | View |
| Control | Participants in this group will receive placebo once weekly injection in addition to their standard closed-loop therapy Placebo: Injection placebo up to 1 mg per week in addition to standard closed-loop therapy | 0 | None | 0 | 36 | 11 | 36 | View |
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Nausea & vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |